Safety and Efficacy of Acalabrutinib and Obinutuzumab in Treatment-Naive Chronic Lymphocytic Leukemia: a Japanese Phase 1 Study

Jun Takizawa,Takanori Teshima,Daisuke Ennishi,Satoshi Ichikawa,Ritsuro Suzuki, Akira Kojima, Yusuke Takahashi,Nobuya Hayashi,Hisashi Kawasumi,Kosho Murayama,Patricia Cheung, Toshio Kawata,Koji Izutsu

Leukemia & lymphoma（2024）

引用 0|浏览5
暂无评分
关键词
Bruton tyrosine kinase inhibitor,combination therapy,targeted therapy,pharmacokinetics,pharmacodynamics
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要